MDxHealth SA - Ordinary Shares (MDXH)

MDxHealth reported mixed Q3 2025 results with 18% revenue growth and a key milestone of positive adjusted EBITDA, despite missing top-line estimates.

MDxHealth (MDXH) stock shows strong technical uptrend and fundamental growth momentum, meeting criteria for high-growth investors.

After months of work, we’re proud to release the Master Swing Trading Course - a 175-page deep dive designed from your feedback and our three decades of market experience.

MDXH stock results show that MDxHealth missed analyst estimates for earnings per share but beat on revenue for the second quarter of 2024.

MDXH stock results show that MDxHealth missed analyst estimates for earnings per share but beat on revenue for the first quarter of 2024.

MDxHealth SA (NASDAQ: MDXH) reported better-than-expected sales for its fourth quarter on Wednesday.

With U.S. stock futures trading lower this morning on Tuesday, some of the stocks that may grab investor focus today are as follows:

Gainers SuperCom Ltd. (NASDAQ: SPCB) shares jumped 89% to $0.6805, after falling 13% on Monday.

Companies Reporting Before The Bell • CTS (NYSE:CTS) is estimated to report quarterly earnings at $0.14 per share on revenue of $708.85 million.

Gainers Edible Garden AG Incorporated (NASDAQ: EDBL) shares jumped 58% to $1.88 after the company reported better-than-expected second-quarter financial results.

Gainers PHAXIAM Therapeutics S.A. (NASDAQ: PHXM) shares surged 46.7% to $0.64 in pre-market trading after gaining 6% on Wednesday.

We're starting off the day with a breakdown of the biggest pre-market stock movers traders should watch on Thursday morning!